Annis Gardner Whiting Capital Advisors LLC cut its stake in Aflac Incorporated (NYSE:AFL – Free Report) by 15.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 941 shares of the financial services provider’s stock after selling 172 shares during the period. Annis Gardner Whiting Capital Advisors LLC’s holdings in Aflac were worth $97,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of AFL. Motley Fool Asset Management LLC increased its holdings in shares of Aflac by 12.9% during the 4th quarter. Motley Fool Asset Management LLC now owns 25,451 shares of the financial services provider’s stock worth $2,633,000 after buying an additional 2,910 shares during the last quarter. World Investment Advisors increased its stake in Aflac by 28.4% during the fourth quarter. World Investment Advisors now owns 6,817 shares of the financial services provider’s stock worth $705,000 after acquiring an additional 1,507 shares during the last quarter. OneAscent Financial Services LLC raised its holdings in shares of Aflac by 16.1% in the 4th quarter. OneAscent Financial Services LLC now owns 2,349 shares of the financial services provider’s stock worth $243,000 after purchasing an additional 326 shares during the period. Creekmur Asset Management LLC grew its holdings in shares of Aflac by 50.2% during the 4th quarter. Creekmur Asset Management LLC now owns 17,621 shares of the financial services provider’s stock worth $1,823,000 after purchasing an additional 5,888 shares during the period. Finally, Huntington National Bank increased its position in Aflac by 10.5% during the 4th quarter. Huntington National Bank now owns 223,793 shares of the financial services provider’s stock worth $23,149,000 after purchasing an additional 21,338 shares in the last quarter. 67.44% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other news, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. This represents a 37.36 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the transaction, the director now owns 25,393 shares of the company’s stock, valued at $2,733,048.59. This represents a 3.79 % decrease in their position. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Check Out Our Latest Analysis on AFL
Aflac Stock Performance
Shares of AFL stock opened at $101.94 on Friday. The stock has a market capitalization of $55.64 billion, a price-to-earnings ratio of 10.62, a PEG ratio of 3.24 and a beta of 0.81. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50. The company’s 50-day simple moving average is $106.95 and its 200-day simple moving average is $107.71. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10.
Aflac (NYSE:AFL – Get Free Report) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Equities analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
See Also
- Five stocks we like better than Aflac
- What is Forex and How Does it Work?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- 5 discounted opportunities for dividend growth investors
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.